Article Versions Notes

Yamamoto Y, Maetani T, Narita H, Terasawa Y, Kato N, Akasaki Y, Murayama Y, Tanaka T. Alteration of Prognostic Factors for Patients with Brain Metastases from Lung Cancer Before and After the Introduction of Immune Checkpoint Inhibitors: A Retrospective Single-Institution Study. Cancers. 2025; 17(18):3067. https://doi.org/10.3390/cancers17183067

Yamamoto, Yohei, Tomona Maetani, Hiroki Narita, Yurika Terasawa, Naoki Kato, Yasuharu Akasaki, Yuichi Murayama, and Toshihide Tanaka. 2025. "Alteration of Prognostic Factors for Patients with Brain Metastases from Lung Cancer Before and After the Introduction of Immune Checkpoint Inhibitors: A Retrospective Single-Institution Study" Cancers 17, no. 18: 3067. https://doi.org/10.3390/cancers17183067

Yamamoto, Y., Maetani, T., Narita, H., Terasawa, Y., Kato, N., Akasaki, Y., Murayama, Y., & Tanaka, T. (2025). Alteration of Prognostic Factors for Patients with Brain Metastases from Lung Cancer Before and After the Introduction of Immune Checkpoint Inhibitors: A Retrospective Single-Institution Study. Cancers, 17(18), 3067. https://doi.org/10.3390/cancers17183067